The pathogenesis of cell death in Parkinson's disease–2007

CW Olanow - Movement disorders: official journal of the …, 2007 - Wiley Online Library
A number of factors have been implicated in the pathogenesis of cell death in Parkinson's
disease (PD). These include oxidative stress, mitochondrial dysfunction, inflammation …

Oxidative stress in glaucoma: a burden of evidence

DM Kumar, N Agarwal - Journal of glaucoma, 2007 - journals.lww.com
Glaucoma is an insidiously progressive optic neuropathy which affects nearly 90 million
people worldwide, and is the leading cause of irreversible blindness. 1–3 It is a …

p53 protein, interferon-γ, and NF-κB levels are elevated in the parkinsonian brain

M Mogi, T Kondo, Y Mizuno, T Nagatsu - Neuroscience letters, 2007 - Elsevier
We and other workers found markedly increased levels of proinflammatory cytokines and
apoptosis-related proteins in parkinsonian brain. Although the pathogenesis of Parkinson's …

p53‐dependent neuronal cell death in a DJ‐1‐deficient zebrafish model of Parkinson's disease

S Bretaud, C Allen, PW Ingham… - Journal of …, 2007 - Wiley Online Library
Mutations in DJ‐1 lead to early onset Parkinson's disease (PD). The aim of this study was to
elucidate further the underlying mechanisms leading to neuronal cell death in DJ‐1 …

Apoptotic mechanisms in mutant LRRK2-mediated cell death

C Iaccarino, C Crosio, C Vitale, G Sanna… - Human molecular …, 2007 - academic.oup.com
Mutations in the gene coding for leucine-rich repeat kinase 2 (LRRK2) cause autosomal-
dominant Parkinson's disease. The pathological mutations have been associated with an …

Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide

S Singh, M Dikshit - Brain research reviews, 2007 - Elsevier
Apoptosis of nigral dopaminergic neurons by various mechanisms is an emerging
phenomenon involved in the degeneration of dopaminergic neurons in Parkinson's disease …

Melatonin protects against rotenone‐induced oxidative stress in a hemiparkinsonian rat model

KS Saravanan, KM Sindhu… - Journal of pineal …, 2007 - Wiley Online Library
In the present study, we evaluated the effect of melatonin, a well‐known free radical
scavenger and neuroprotector, against rotenone‐induced oxidative stress in a …

Rasagiline–a novel MAO B inhibitor in Parkinson's disease therapy

S Lecht, S Haroutiunian, A Hoffman… - … and clinical risk …, 2007 - Taylor & Francis
Parkinson's disease (PD) is a progressive neurodegenerative, dopamine deficiency
disorder. The main therapeutic strategies for PD treatment relies on dopamine precursors …

Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease

V Anantharam, E Lehrmann, A Kanthasamy… - Neurochemistry …, 2007 - Elsevier
Oxidative stress and apoptotic cell death have been implicated in the dopaminergic cell loss
that characterizes Parkinson's disease. While factors contributing to apoptotic cell death are …

NF-κB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53

ZQ Liang, YL Li, XL Zhao, R Han, XX Wang, Y Wang… - Brain research, 2007 - Elsevier
To evaluate the contribution of NF-κB and the NF-κB target gene p53 to nigral dopaminergic
neuron degeneration in rodent models of Parkinson's disease, time-course of dopaminergic …